The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, Guy M., Knopman, David S., Chertkow, Howard, Hyman, Bradley T., Jack, Clifford R., Kawas, Claudia H., Klunk, William E., Koroshetz, Walter J. +10 more·2011·Alzheimer's & Dementia
DOI 10.1016/j.jalz.2011.03.005

Cited by (1,513)

Items 401–500 of 1,513

  1. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
    Patrizia Mecocci, Maria Cristina Polidori · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  2. Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
    Johnson, Keith A., Sperling, Reisa A., Gidicsin, Christopher M., Carmasin, Jeremy S., Maye, Jacqueline E., Coleman, Ralph E., Reiman, Eric M., Sabbagh, Marwan N., Sadowsky, Carl H., Fleisher, Adam S. et al. · 2013 · Alzheimer's & Dementia
  3. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis
    Yue You, Zhizhen Liu, Yannan Chen, Ying Xu, Jiawei Qin, Shuai Guo, Jia Huang, Jing Tao · 2021 · Acta Diabetologica
  4. Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
    Nicholas C. Cullen, Antoine Leuzy, Shorena Janelidze, Sebastian Palmqvist, Anna L. Svenningsson, Erik Stomrud, Jeffrey L. Dage, Niklas Mattsson, Oskar Hansson · 2021 · Nature Communications
  5. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study
    Moulin, Solène, Labreuche, Julien, Bombois, Stéphanie, Rossi, Costanza, Boulouis, Gregoire, Hénon, Hilde, Duhamel, Alain, Leys, Didier, Cordonnier, Charlotte · 2016 · The Lancet Neurology
  6. Longitudinal tau accumulation and atrophy in aging and alzheimer disease
    Theresa M. Harrison, Renaud La Joie, Anne Maaß, Suzanne L. Baker, Kaitlin N. Swinnerton, Laura E. Fenton, Taylor J. Mellinger, Lauren Edwards, Julie Q. Pham, Bruce L. Miller et al. · 2018 · Annals of Neurology
  7. The biological pathways of Alzheimer disease: a review
    Marco Calabrò, Carmela Rinaldi, Giuseppe Santoro, Concetta Crisafulli · 2020 · AIMS neuroscience
  8. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection
    Stefan Johannes Teipel, Alexander E. Drzezga, Michel J. Grothe, Henryk Barthel, Gaël Chételat, Norbert W. Schuff, Pawel Skudlarski, Enrica Cavedo, Giovanni Battista Frisoni, Wolfgang U. Hoffmann et al. · 2015 · The Lancet Neurology
  9. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment, and early Alzheimer’s disease
    Croteau, E., Castellano, C.A., Fortier, M., Bocti, C., Fulop, T., Paquet, N., Cunnane, S.C. · 2018 · Experimental Gerontology
  10. Mild cognitive impairment due to Alzheimer disease in the community
    Petersen, Ronald C., Aisen, Paul, Boeve, Bradley F., Geda, Yonas E., Ivnik, Robert J., Knopman, David S., Mielke, Michelle, Pankratz, Vernon S., Roberts, Rosebud, Rocca, Walter A. et al. · 2013 · Annals of Neurology
  11. Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach
    Christian Salvatore, Antonio Cerasa, Petronilla Battista, Maria Carla Gilardi, Aldo Quattrone, Isabella Castiglioni · 2015 · Frontiers in Neuroscience
  12. Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid
    Lleó, Alberto, Núñez-Llaves, Raúl, Alcolea, Daniel, Chiva, Cristina, Balateu-Paños, Daniel, Colom-Cadena, Martí, Gomez-Giro, Gemma, Muñoz, Laia, Querol-Vilaseca, Marta, Pegueroles, Jordi et al. · 2019 · Molecular & Cellular Proteomics
  13. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
    Pontecorvo, Michael J, Devous, Michael D, Kennedy, Ian, Navitsky, Michael, Lu, Ming, Galante, Nicholas, Salloway, Stephen, Doraiswamy, P Murali, Southekal, Sudeepti, Arora, Anupa K et al. · 2019 · Brain
  14. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0
    Satoshi Minoshima, Alexander E. Drzezga, Henryk Barthel, Nicolaas Ida Bohnen, Mehdi Djekidel, David H. Lewis, Chester A. Mathis, Jonathan McConathy, Agneta K. Nordberg, Osama Sabri et al. · 2016 · Journal of Nuclear Medicine
  15. The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review
    Marianne Chapleau, Leonardo Iaccarino, David N. Soleimani‐Meigooni, Gil Dan Rabinovici · 2022 · Journal of Nuclear Medicine
  16. Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset
    Davide Chiasserini, Jan R.T. van Weering, Sander R. Piersma, Thang V. Pham, Arjan Malekzadeh, Charlotte Elisabeth Teunissen, Heidi de Wit, Connie R. Jiménez · 2014 · Journal of Proteomics
  17. The impact of bilingualism on brain reserve and metabolic connectivity in Alzheimer's dementia
    Daniela Perani, Mohsen Farsad, Tommaso Ballarini, Francesca Lubian, Maura Malpetti, Alessandro Fracchetti, Giuseppe Magnani, Albert March, Jubin Abutalebi · 2017 · Proceedings of the National Academy of Sciences
  18. Diagnostic power of resting‐state fMRI for detection of network connectivity in Alzheimer's disease and mild cognitive impairment: A systematic review
    Buhari Ibrahim, Subapriya Suppiah, Normala Ibrahim, Mazlyfarina Mohamad, Hasyma Abu Hassan, Nisha Syed Nasser, M. Iqbal Saripan · 2021 · Human Brain Mapping
  19. Converging evidence for the neuroanatomic basis of combinatorial semantics in the angular gyrus
    Price, Amy R., Bonner, Michael F., Peelle, Jonathan E., Grossman, Murray · 2015 · The Journal of Neuroscience
  20. A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
    Brum, Wagner S., Cullen, Nicholas C., Janelidze, Shorena, Ashton, Nicholas J., Zimmer, Eduardo R., Therriault, Joseph, Benedet, Andrea L., Rahmouni, Nesrine, Tissot, Cécile, Stevenson, Jenna et al. · 2023 · Nature Aging
  21. Insulin resistance predicts brain amyloid deposition in late middle‐aged adults
    Auriel A. Willette, Sterling C. Johnson, Alex C. Birdsill, Mark A. Sager, Bradley Christian, Laura D. Baker, Suzanne Craft, Jennifer M. Oh, E. H. Statz, Bruce P. Hermann et al. · 2014 · Alzheimer s & Dementia
  22. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias
    Mark M. Yarchoan, Sharon Xiangwen Xie, Mitchel A. Kling, Jon B. Toledo, David A. Wolk, Eddie B Lee, Vivianna M. Van Deerlin, V. M.- Y. Lee, John Q. Trojanowski, Steven Edward Arnold · 2012 · Brain
  23. Ocular indicators of Alzheimer’s: exploring disease in the retina
    Nadav J. Hart, Yosef Koronyo, Keith L. Black, Maya Koronyo‐Hamaoui · 2016 · Acta Neuropathologica
  24. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
    Whelan, Christopher D., Mattsson, Niklas, Nagle, Michael W., Vijayaraghavan, Swetha, Hyde, Craig, Janelidze, Shorena, Stomrud, Erik, Lee, Julie, Fitz, Lori, Samad, Tarek A. et al. · 2019 · Acta Neuropathologica Communications
  25. Atypical aging in down syndrome
    Warren B. Zigman · 2013 · Developmental Disabilities Research Reviews
  26. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study
    Flora Hillegonde Duits, Pablo Martínez‐Lage, Claire Paquet, Sebastiaan Engelborghs, Alberto Lleó, Lucrezia Hausner, José Luís Molinuevo, Erik Stomrud, Lucia Farotti, Inez H.G.B. Ramakers et al. · 2015 · Alzheimer s & Dementia
  27. Mild cognitive impairment: pathology and mechanisms
    Elliott Jay Mufson, Lester I. Binder, Scott Counts, Steven Trent DeKosky, Leyla deToledo‐Morrell, Stephen D. Ginsberg, Miloš D. Ikonomović, Sylvia E. Perez, Stephen W. Scheff · 2011 · Acta Neuropathologica
  28. Multi-modal classification of Alzheimer's disease using nonlinear graph fusion
    Tong Tong, Katherine R. Gray, Qinquan Gao, Liang Chen, Daniel Rueckert · 2016 · Pattern Recognition
  29. Current evidence on the effect of dietary polyphenols intake on chronic diseases
    Chiara Costa, Aristidis Michael Tsatsakis, Charalampos Mamoulakis, Michele Teodoro, Giusi Briguglio, Emanuela Caruso, Dimitris Tsoukalas, Denisa Marilena Margina, Efthimios Dardiotis, Demetrios Kouretas et al. · 2017 · Food and Chemical Toxicology
  30. Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma
    Kayoung Kim, Minji Kim, Da Won Kim, Su Yeong Kim, Steve Park, Chan Beum Park · 2020 · Nature Communications
  31. White matter hyperintensities: relationship to amyloid and tau burden
    Graff-Radford, Jonathan, Arenaza-Urquijo, Eider M, Knopman, David S, Schwarz, Christopher G, Brown, Robert D, Rabinstein, Alejandro A, Gunter, Jeffrey L, Senjem, Matthew L, Przybelski, Scott A, Lesnick, Timothy et al. · 2019 · Brain
  32. Regional White Matter Hyperintensity Volume, Not Hippocampal Atrophy, Predicts Incident Alzheimer Disease in the Community
    Adam M. Brickman, Frank A. Provenzano, Jordan Muraskin, Jennifer Jaie Manly, Sonja Blum, Zoltan L. Apa, Yaakov Stern, Truman R. Brown, Jose Alejandro Luchsinger, Richard P Mayeux · 2012 · Archives of Neurology
  33. Machine learning in medicine: Performance calculation of dementia prediction by support vector machines (SVM)
    Gopi Battineni, Nalini Chintalapudi, Francesco Amenta · 2019 · Informatics in Medicine Unlocked
  34. Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
    Fernando González‐Ortiz, Michael Turton, Przemysław Radosław Kac, Denis S. Smirnov, Enrico Premi, Roberta Ghidoni, Luisa Benussi, Valentina Cantoni, Claudia Saraceno, Jasmine Rivolta et al. · 2022 · Brain
  35. Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism
    Brown, Richard K. J., Bohnen, Nicolaas I., Wong, Ka Kit, Minoshima, Satoshi, Frey, Kirk A. · 2014 · RadioGraphics
  36. Cognitive Dysfunction Syndrome
    Gary M Landsberg, Jeff Nichol, Joseph A. Araujo · 2012 · Veterinary Clinics of North America Small Animal Practice
  37. Impaired Long Distance Functional Connectivity and Weighted Network Architecture in Alzheimer's Disease
    Yong Liu, Chunshui Yu, Xinqing Zhang, Jieqiong Liu, Yunyun Duan, Aaron F. Alexander‐Bloch, Bing Liu, Tianzi Jiang, Edward Thomas Bullmore · 2013 · Cerebral Cortex
  38. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
    Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, David S. Knopman, Michelle M. Mielke, Prashanthi Vemuri, Val J. Lowe, Matthew L. Senjem, Jeffrey L. Gunter, Denise A. Reyes et al. · 2015 · Brain
  39. Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET
    de Leon, Mony J., Li, Yi, Okamura, Nobuyuki, Tsui, Wai H., Saint-Louis, Les A., Glodzik, Lidia, Osorio, Ricardo S., Fortea, Juan, Butler, Tracy, Pirraglia, Elizabeth et al. · 2017 · Journal of Nuclear Medicine
  40. Epidemiological and Economic Burden of Alzheimer's Disease: A Systematic Literature Review of Data across Europe and the United States of America
    Claire Takizawa, Paula Louise Thompson, Anneloes van Walsem, Céline Faure, William C. Maier · 2014 · Journal of Alzheimer s Disease
  41. Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
    Lee, Jinny Claire, Kim, Soo Jung, Hong, Seungpyo, Kim, YoungSoo · 2019 · Experimental & Molecular Medicine
  42. Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
    Matthew C. L. Phillips, Laura Deprez, Grace M. N. Mortimer, Deborah K. J. Murtagh, Stacey L. McCoy, Ruth Mylchreest, Linda J. Gilbertson, Karen M. Clark, Patricia V. Simpson, Eileen J. McManus et al. · 2021 · Alzheimer s Research & Therapy
  43. Early intervention in Alzheimer’s disease: a health economic study of the effects of diagnostic timing
    Jennifer H. Barnett, Lily M. Lewis, Andrew D. Blackwell, Matthew Taylor · 2014 · BMC Neurology
  44. Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update
    Huang, Li-Kai, Kuan, Yi-Chun, Lin, Ho-Wei, Hu, Chaur-Jong · 2023 · Journal of Biomedical Science
  45. Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
    Longfei Jia, Min Zhu, Chaojun Kong, Yana Pang, Heng Zhang, Qiongqiong Qiu, Cuibai Wei, Yi Tang, Qi Wang, Ying Li et al. · 2020 · Alzheimer s & Dementia
  46. Alzheimer Disease
    Liana G. Apostolova · 2016 · CONTINUUM Lifelong Learning in Neurology
  47. Subjective Cognitive Complaints Contribute to Misdiagnosis of Mild Cognitive Impairment
    Edmonds, Emily C., Delano-Wood, Lisa, Galasko, Douglas R., Salmon, David P., Bondi, Mark W. · 2014 · Journal of the International Neuropsychological Society
  48. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression
    Willem Huijbers, Elizabeth C. Mormino, Aaron P. Schultz, Sarah E. Wigman, Andrew M. Ward, Mykol Larvie, Rebecca England Amariglio, Gad A. Marshall, Dorene M. Rentz, Keith A. Johnson et al. · 2015 · Brain
  49. Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
    Thomas Cope, Timothy Rittman, Robin Jacob Borchert, Peter Simon Jones, Deniz Vatansever, Kieren S. J. Allinson, Luca Passamonti, Patricia Vázquez Rodríguez, William Richard Bevan-Jones, John Tiernan O'Brien et al. · 2017 · Brain
  50. Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
    Elizabeth Morris, Anastasia Chalkidou, Alexander Hammers, Janet L. Peacock, Jennifer A. Summers, Stephen Keevil · 2015 · European Journal of Nuclear Medicine and Molecular Imaging
  51. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules
    Chris Greene, Matthew Campbell · 2016 · Tissue Barriers
  52. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis
    Paul C. Donaghy, Ian Grant McKeith · 2014 · Alzheimer s Research & Therapy
  53. Gamma oscillations in cognitive disorders
    Alexandra J. Mably, Laura Lee Colgin · 2018 · Current Opinion in Neurobiology
  54. Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction
    Ungar, Leo, Altmann, Andre, Greicius, Michael D. · 2014 · Brain Imaging and Behavior
  55. Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
    Chang, Chun-Hung, Lin, Chieh-Hsin, Lane, Hsien-Yuan · 2021 · International Journal of Molecular Sciences
  56. Cognitive intervention in amnestic Mild Cognitive Impairment: A systematic review
    Sharon Sanz Simon, Juliana Emy Yokomizo, Cássio M. C. Bottino · 2012 · Neuroscience & Biobehavioral Reviews
  57. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease
    Kathryn G. Goozee, Tejal M. Shah, Hamid Reza Sohrabi, Stephanie Ruth Rainey‐Smith, Belinda M. Brown, Giuseppe Verdile, Ralph Nigel Martins · 2015 · British Journal Of Nutrition
  58. Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk
    McQuade, Amanda, Blurton-Jones, Mathew · 2019 · Journal of Molecular Biology
  59. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
    Mattsson, Niklas, Insel, Philip S., Donohue, Michael, Landau, Susan, Jagust, William J., Shaw, Leslie M., Trojanowski, John Q., Zetterberg, Henrik, Blennow, Kaj, Weiner, Michael W. · 2015 · Brain
  60. Nutrition for the ageing brain: Towards evidence for an optimal diet
    Vauzour, David, Camprubi-Robles, Maria, Miquel-Kergoat, Sophie, Andres-Lacueva, Cristina, Bánáti, Diána, Barberger-Gateau, Pascale, Bowman, Gene L., Caberlotto, Laura, Clarke, Robert, Hogervorst, Eef et al. · 2017 · Ageing Research Reviews
  61. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults
    Kate E. Sprecher, Barbara B. Bendlin, Annie Marie Racine, Ozioma C. Okonkwo, Bradley T. Christian, Rebecca L. Koscik, Mark A. Sager, Sanjay Asthana, Sterling C. Johnson, Ruth M. Benca · 2015 · Neurobiology of Aging
  62. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
    Magnus Gisslén, Richard W. Price, Staffan Nilsson · 2011 · BMC Infectious Diseases
  63. Retinal thickness in Alzheimer's disease: A systematic review and meta‐analysis
    Jurre den Haan, Frank D. Verbraak, Pieter Jelle Visser, Femke H. Bouwman · 2017 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  64. Functional connectivity associated with tau levels in ageing, Alzheimer’s, and small vessel disease
    Nicolai Franzmeier, Anna Rubinski, Julia Neitzel, Yeshin Kim, Alexander Damm, Duk Lyul Na, Hee Jin Kim, Chul Hyoung Lyoo, Hanna Cho, Sofia Finsterwalder et al. · 2019 · Brain
  65. Clinical amyloid imaging in Alzheimer's disease
    Herholz, Karl, Ebmeier, Klaus · 2011 · The Lancet Neurology
  66. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study
    Adam Fleisher, Kewei Chen, Yakeel T. Quiroz, Laura J. Jakimovich, Madelyn Gutierrez Gomez, Carolyn M. Langois, Jessica B. S. Langbaum, Napatkamon Ayutyanont, Auttawut Roontiva, Pradeep Thiyyagura et al. · 2012 · The Lancet Neurology
  67. A Feasibility Study with Image-Based Rendered Virtual Reality in Patients with Mild Cognitive Impairment and Dementia
    Valéria Manera, Emmanuelle Chapoulie, Jérémy Bourgeois, Rachid Guerchouche, Renaud David, Jan Ondřej, George Drettakis B, Philippe Henri Robert · 2016 · PLoS ONE
  68. Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale
    Navitsky, Michael, Joshi, Abhinay D., Kennedy, Ian, Klunk, William E., Rowe, Christopher C., Wong, Dean F., Pontecorvo, Michael J., Mintun, Mark A., Devous, Michael D. · 2018 · Alzheimer's & Dementia
  69. 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
    Soininen, Hilkka, Solomon, Alina, Visser, Pieter Jelle, Hendrix, Suzanne B, Blennow, Kaj, Kivipelto, Miia, Hartmann, Tobias, Hallikainen, Ilona, Hallikainen, Merja, Helisalmi, Seppo et al. · 2017 · The Lancet Neurology
  70. A noradrenergic theory of cognitive reserve: implications for Alzheimer's disease
    Ian Hamilton Robertson · 2012 · Neurobiology of Aging
  71. Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging
    Kapogiannis, Dimitrios, Mustapic, Maja, Shardell, Michelle D., Berkowitz, Sean T., Diehl, Thomas C., Spangler, Ryan D., Tran, Joyce, Lazaropoulos, Michael P., Chawla, Sahil, Gulyani, Seema et al. · 2019 · JAMA Neurology
  72. On the right side? A longitudinal study of left- versus right-lateralized semantic dementia
    Kumfor, Fiona, Landin-Romero, Ramon, Devenney, Emma, Hutchings, Rosalind, Grasso, Roberto, Hodges, John R., Piguet, Olivier · 2016 · Brain
  73. Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer's or vascular type: a review
    Bahar-Fuchs, Alex, Clare, Linda, Woods, Bob · 2013 · Alzheimer's Research & Therapy
  74. The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline
    Corriveau, Roderick A., Bosetti, Francesca, Emr, Marian, Gladman, Jordan T., Koenig, James I., Moy, Claudia S., Pahigiannis, Katherine, Waddy, Salina P., Koroshetz, Walter · 2016 · Cellular and Molecular Neurobiology
  75. Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment
    Giulio Maria Pasinetti, Jun Wang, Lap Ho, Wei Zhao, Lauren Dubner · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  76. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease
    Paul T. Maruff, Yen Ying Lim, David Darby, Kathryn A. Ellis, Robert H. Pietrzak, Peter Jeffrey Snyder, Ashley Ian Bush, Cassandra E. I. Szoeke, Adrian J. Schembri, David J. Ames et al. · 2013 · BMC Psychology
  77. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum
    David Thomas Jones, Jonathan Graff‐Radford, Val J. Lowe, Heather J. Wiste, Jeffrey L. Gunter, Matthew L. Senjem, Hugo Botha, Kejal Kantarci, Bradley F. Boeve, David S. Knopman et al. · 2017 · Cortex
  78. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
    Bruno Dubois, Stéphane Epelbaum, Francis Nyasse, Hovagim Bakardjian, Geoffroy Pierre Gagliardi, Olga Uspenskaya, Marion Houot, Simone Lista, Federica Cacciamani, Marie‐Claude Potier et al. · 2018 · The Lancet Neurology
  79. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein
    Chul Hyoung Lyoo, Masamichi Ikawa, Jeih‐San Liow, Sami S. Zoghbi, Cheryl L. Morse, Victor William Pike, Masahiro Fujita, Robert B. Innis, William Charles Kreisl · 2015 · Journal of Nuclear Medicine
  80. Rab GTPases and Membrane Trafficking in Neurodegeneration
    Ferdi Rıdvan Kiral, Friederike Elisabeth Kohrs, Eugene Jennifer Jin, P. Robin Hiesinger · 2018 · Current Biology
  81. Measuring the effects of aging and sex on regional brain stiffness with MR elastography in healthy older adults
    Arani, Arvin, Murphy, Matthew C., Glaser, Kevin J., Manduca, Armando, Lake, David S., Kruse, Scott A., Jack, Clifford R., Ehman, Richard L., Huston, John · 2015 · NeuroImage
  82. Atrophy patterns in early clinical stages across distinct phenotypes of <scp>A</scp> lzheimer's disease
    Ossenkoppele, Rik, Cohn‐Sheehy, Brendan I., La Joie, Renaud, Vogel, Jacob W., Möller, Christiane, Lehmann, Manja, van Berckel, Bart N.M., Seeley, William W., Pijnenburg, Yolande A., Gorno‐Tempini, Maria L. et al. · 2015 · Human Brain Mapping
  83. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
    Denk, Johannes, Boelmans, Kai, Siegismund, Christine, Lassner, Dirk, Arlt, Sönke, Jahn, Holger · 2015 · PLOS ONE
  84. Metabolic and Non-Cognitive Manifestations of Alzheimer’s Disease: The Hypothalamus as Both Culprit and Target of Pathology
    Makoto Ishii, Costantino Iadecola · 2015 · Cell Metabolism
  85. Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias
    Melissa Erin Murray, Naomi Kouri, Wen-Lang Lin, Clifford R. Jack, Dennis W. Dickson, Prashanthi Vemuri · 2014 · Alzheimer s Research & Therapy
  86. Brain fluorodeoxyglucose (FDG) PET in dementia
    Kato, Takashi, Inui, Yoshitaka, Nakamura, Akinori, Ito, Kengo · 2016 · Ageing Research Reviews
  87. Management of mild cognitive impairment (MCI): The need for national and international guidelines
    Siegfried F. Kasper, C. Bancher, Anne Eckert, Hans Förstl, Lutz Frölich, Jakub Hort, Amos D. Korczyn, Reto Werner Kressig, Oleg Semenovich Levin, María Sagrario Manzano Palomo · 2020 · The World Journal of Biological Psychiatry
  88. Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance
    Passamonti, L., Tsvetanov, K.A., Jones, P.S., Bevan-Jones, W.R., Arnold, R., Borchert, R.J., Mak, E., Su, L., O'Brien, J.T., Rowe, J.B. · 2019 · The Journal of Neuroscience
  89. The future of Alzheimer's disease: The next 10 years
    Harald Juergen Hampel, David Prvulovic, Stefan Johannes Teipel, Frank Jessen, Christian Luckhaus, Lutz Frölich, Matthias W. Riepe, Richard C. Dodel, Thomas Leyhe, Lars Bertram et al. · 2011 · Progress in Neurobiology
  90. Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts
    Paolo Maria Rossini, Riccardo Di Iorio, Fabrizio Vecchio, Maria Anfossi, Claudio Babiloni, Marco Bozzali, Amalia Cecilia Bruni, Stefano Francesco Cappa, Javier Escudero, Francisco J. Fraga et al. · 2020 · Clinical Neurophysiology
  91. Neuronal cell death mechanisms in Alzheimer’s disease: An insight
    Parul Goel, Sasanka Chakrabarti, Kapil Goel, Karanpreet Bhutani, Tanya Chopra, Sharadendu Bali · 2022 · Frontiers in Molecular Neuroscience
  92. Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
    Diane Chan, Ho‐Jun Suk, Brennan Jackson, Noah Milman, Danielle Stark, Elizabeth B. Klerman, Erin G. Kitchener, Vanesa S. Fernandez Avalos, Gabrielle de Weck, Arit Banerjee et al. · 2022 · PLoS ONE
  93. Prevalence and outcomes of amyloid positivity among persons without dementia in a longitudinal, population-based setting
    Roberts, Rosebud O., Aakre, Jeremiah A., Kremers, Walter K., Vassilaki, Maria, Knopman, David S., Mielke, Michelle M., Alhurani, Rabe, Geda, Yonas E., Machulda, Mary M., Coloma, Preciosa et al. · 2018 · JAMA Neurology
  94. Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-Analysis
    Canevelli, Marco, Grande, Giulia, Lacorte, Eleonora, Quarchioni, Elisa, Cesari, Matteo, Mariani, Claudio, Bruno, Giuseppe, Vanacore, Nicola · 2016 · Journal of the American Medical Directors Association
  95. Subregional Basal Forebrain Atrophy in Alzheimer's Disease: A Multicenter Study
    Ingo Kilimann, Michel J. Grothe, Helmut Heinsen, Eduardo Joaquim Lopes Alho, Lea T. Grinberg, Edson Amaro, Gláucia Aparecida Bento dos Santos, Rafael Emídio da Silva, Alex J. Mitchell, Giovanni Battista Frisoni et al. · 2014 · Journal of Alzheimer s Disease
  96. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)
    Frank Jessen, Annika E. Spottke, Henning Boecker, Frederic Brosseron, Katharina Büerger, Cihan Catak, Klaus Fließbach, Christiana Franke, Manuel Fuentes, Michael Thomas Heneka et al. · 2018 · Alzheimer s Research & Therapy
  97. Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline
    Rossana Botto, Nicoletta Callai, Aurora Cermelli, Lorenzo Causarano, Innocenzo Rainero · 2022 · Neurological Sciences
  98. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer’s disease
    Chatterjee, Pratishtha, Pedrini, Steve, Ashton, Nicholas J., Tegg, Michelle, Goozee, Kathryn, Singh, Abhay K., Karikari, Thomas K., Simrén, Joel, Vanmechelen, Eugeen, Armstrong, Nicola J. et al. · 2022 · Alzheimer's &amp; Dementia
  99. A Nationwide Survey of Mild Cognitive Impairment and Dementia, Including Very Mild Dementia, in Taiwan
    Yu Sun, Huey-Jane Lee, Shu-Chien Yang, Ta‐Fu Chen, Ker-Neng Lin, Chung‐Chih Lin, Pei‐Ning Wang, Li-Yu Tang, Ming‐Jang Chiu · 2014 · PLoS ONE
  100. d-serine levels in Alzheimer’s disease: implications for novel biomarker development
    Caroline Madeira, Mychael V. Lourenco, Charles Vargas-Lopes, Cláudia Kimie Suemoto, Carlos Otávio Brandão, Taylor Reis, Renata Elaine Paraízo Leite, Jerson Laks, W Jacob-Filho, Carlos Augusto Pasqualucci et al. · 2015 · Translational Psychiatry